格林美(002340.SZ):擬出售不超250萬股歐科億股票
格隆匯12月13日丨格林美(002340.SZ)公佈,公司直接持有上海證券交易所科創板上市公司株洲歐科億數控精密刀具股份有限公司(證券簡稱:歐科億;證券代碼:688308)股票1500.24萬股,佔其總股本的15%。
為優化公司資產結構,提高資產流動性及使用效率,滿足公司未來發展的資金需求,公司於2021年12月13日召開第五屆董事會第三十九次會議,審議通過了《關於擬出售股票資產的議案》,同意公司董事會授權公司管理層辦理本次出售歐科億部分股票的相關事宜,出售數量不超過250萬股,授權範圍包括但不限於根據交易市場情況確定具體出售時機、交易方式、交易數量、交易價格、簽署相關協議等,授權期限自本次董事會審議通過之日起12個月內。在上述授權期限內,若歐科億發生送股、資本公積轉增股本等情況,擬出售的股票數量相應變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.